Topic: AI/ML

Organizers praised Falcone's “extraordinary leadership in driving research directions to advance science and technology at one of America's most vital research institutions.”

News Item

As the application of AI across industries accelerates the pace of development, so too must national security remain at the cutting edge, a task requiring extensive collaboration to deploy the nation’s most critical resources.

News Item

LLNL and Amazon Web Services are partnering to leverage the power of AI to enhance operations at the National Ignition Facility.

News Item

Stanford University professor and AI visionary Fei-Fei Li went beyond technical milestones from her two-decade career into her philosophy of intelligence, ranging from the evolution of vision in the Cambrian Age to modern-day “robot cousins” that can see and assist humans in everyday menial tasks.

News Item

A team of researchers from LLNL, Stanford University, and UCLA are using AI and machine learning to find potential treatments for amyotrophic lateral sclerosis and other neurodegenerative diseases in the form of drugs prescribed for other conditions.

News Item

Wright’s daylong visit included briefings and discussions with LLNL experts in key mission areas including stockpile modernization, fusion energy, AI, cybersecurity and supercomputing.

News Item

On the latest episode of The Big Ideas Lab podcast, listeners will get an inside look at this transformation, as LLNL physicists Brian Spears and Kelli Humbird explain how AI is no longer just about chatbots and automating simple tasks.

News Item

LLNL researchers have posters and workshop papers accepted to the 13th International Conference on Learning Representations on April 24–28.

News Item

Researchers from LLNL, in collaboration with other leading institutions, have successfully used an AI-driven platform to preemptively optimize an antibody to neutralize a broad diversity of SARS-CoV-2 variants.

News Item

More than 3,200 LLNL employees participated in the first-ever aiEDGE for Innovation Day on March 26—an event aimed at empowering and equipping the Lab’s workforce to integrate AI into their daily work.

News Item

Increased resource utilization is one goal of new architectures. At Livermore Computing, these include AI accelerators such as Samba Nova and Cerebras systems and El Capitan's Rabbits.

Project

The February 28 event brought together over 1,400 Department of Energy scientists across multiple sites to explore how cutting-edge AI models could transform scientific research.

News Item

Over the next three years, CASC researchers and collaborators will integrate LLMs into HPC software to boost performance and sustainability.

News Item

Highlights include ML techniques for computed tomography, a scalable Gaussian process framework, safe and trustworthy AI, and autonomous multiscale simulations.

News Item

The latest issue of LLNL's magazine explains how the world’s most powerful supercomputer helps scientists safeguard the U.S. nuclear stockpile.

News Item

LLNL's Bruce Hendrickson joins other HPC luminaries in this op-ed about the future of the field.

News Item

The latest episode of the Big Ideas Lab podcast investigates the use of artificial intelligence for drug discovery and other uses.

News Item

Todd Gamblin has a well-deserved reputation in the HPC software community as a passionate engineer who enjoys rolling up his sleeves and diving into technical problems. It’s not a stretch to see how he got hooked on HPC.

News Item

The DarkStar inverse design technique blends AI, machine learning, and advanced hydrodynamics simulations to optimize science and engineering solutions starting from the final state.

News Item

This interview with HPC-AI Vanguard Kathryn Mohror covers her thoughts on teamwork, her projects, the field, and more.

News Item

SC24, held recently in Atlanta, was a landmark event, setting new records and demonstrating LLNL's unparalleled contributions to HPC innovation and impact.

News Item

The Generative Unconstrained Intelligent Drug Engineering (GUIDE) program accelerates development of medical countermeasure candidates to redefine biological defense.

News Item